| scholarly article | Q13442814 |
| P2093 | author name string | Scott A Rivkees | |
| Yiling Xu | |||
| Diane L McNally | |||
| James J Korelitz | |||
| Mary N Masters | |||
| Sue X Li | |||
| P2860 | cites work | International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets | Q24632195 |
| The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration | Q28251103 | ||
| Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. | Q33849471 | ||
| Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline | Q34703770 | ||
| Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system | Q35955555 | ||
| Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy | Q36823217 | ||
| Therapy insight: management of Graves' disease during pregnancy | Q36827831 | ||
| Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use | Q37420857 | ||
| Thyrotoxicosis | Q37991056 | ||
| Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis | Q40391488 | ||
| Aplasia cutis congenita and methimazole | Q42395313 | ||
| A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy | Q46245863 | ||
| Methimazole embryopathy: a contribution to defining the phenotype. | Q51997183 | ||
| Graves' disease. | Q54276950 | ||
| Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control study | Q57863797 | ||
| Hyperthyroidism in pregnancy | Q60163395 | ||
| Methimazole, carbimazole, and congenital skin defects | Q69682754 | ||
| Thyroid disease in pregnancy | Q84583183 | ||
| P433 | issue | 6 | |
| P921 | main subject | pregnant person | Q104720811 |
| P304 | page(s) | 758-765 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Thyroid | Q15709940 |
| P1476 | title | Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States | |
| P478 | volume | 23 |
| Q57136607 | 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism |
| Q52690094 | Central congenital hypothyroidism caused by maternal thyrotoxicosis. |
| Q41317296 | Comparative frequency of four different types of pregnancy-associated thyrotoxicosis in a single thyroid centre |
| Q35606736 | Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies |
| Q38990879 | Current challenges in the pharmacological management of thyroid dysfunction in pregnancy. |
| Q38822451 | Current trends in antithyroid drug treatment of Graves' disease |
| Q40974447 | Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis. |
| Q34965489 | Evaluation of developmental toxicity of propylthiouracil and methimazole |
| Q92259698 | Gastroschisis Following Treatment with High-Dose Methimazole in Pregnancy: A Case Report |
| Q35814331 | Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system |
| Q51760280 | Global epidemiology of hyperthyroidism and hypothyroidism. |
| Q38707848 | Graves' Disease Pharmacotherapy in Women of Reproductive Age. |
| Q27690661 | Hyperthyroidism |
| Q54288450 | Hyperthyroidism in pregnancy. |
| Q64119695 | Hyperthyroidism in the pregnant woman: Maternal and fetal aspects |
| Q38515111 | Important considerations in the management of Graves' disease in pregnant women. |
| Q38869637 | Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any). |
| Q34185699 | Placenta passage of the thyroid hormone analog DITPA to male wild-type and Mct8-deficient mice |
| Q51064438 | Rethinking antithyroid drugs in pregnancy. |
| Q26859132 | Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis |
| Q34330054 | Severity of birth defects after propylthiouracil exposure in early pregnancy |
| Q48514999 | Topiramate use during pregnancy and major congenital malformations in multiple populations |
| Q31145022 | Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants |
Search more.